Pacific RxTracts - April 2025

Authors

Pacific RxTracts

Files

Description

Articles:

• FDA Approves Miudella: First New Hormone-Free IUD in Over 40 Years
• First Treatment for Cerebrotendinous Xanthomatosis Approved
• Presepsin: A New Biomarker for Assessing Cardiovascular Disease
• New Insights into Severe NOWS Prediction
• Myasthenia Gravis: Nipocalimab, a Potential Add-on Therapy
• ARF/ARDS Concern with Trimethoprim-Sulfamethoxazole in Youth
• Hormone Replacement Therapy: Beneficial for Managing Menopausal Symptoms Long-Term?
• Esketamine Shows Promise in Preventing Postpartum Depression After Cesarean Delivery
• From One Week to One Hour: FDA Approves Label Changes for Sublocade Rapid Induction in Patients with Moderate to Severe Opioid Use Disorder
• Repurposing Semaglutide: A Novel Approach to Alcohol Use Disorder
• Treating Neuropathic Pain: Pregabalin vs. Gabapentin
• Trastuzumab Rezetecan in HER2-Mutant NSCLC: Promising Phase 2 Trial Results
• FDA Approval for Symptomatic Tenosynovial Giant Cell Tumor
• Protecting HIV Patients with Alternative HepB Vaccines
• FDA Approval of New Meningococcal Vaccination Has Greater Serogroup Coverage

Publication Date

4-2-2025

Volume

22

Issue

6

Pages

9

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - April 2025" (2025). Pacific RxTracts. 6.
https://scholarlycommons.pacific.edu/rx-tracts/6